title: Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon.
abstract: In September 2012, a cutaneous leishmaniasis outbreak began among Syrian refugees in Lebanon. For 948 patients in whom leishmaniasis was not confirmed, we obtained samples for microscopic confirmation and molecular speciation. We identified Leishmania tropica in 85% and L. major in 15% of patients. After 3 months of megulamine antimonite therapy, patients initial cure rate was 82%.
authors.forename: Maya
authors.initials: M
authors.lastname: Saroufim
authors.forename: Khalil
authors.initials: K
authors.lastname: Charafeddine
authors.forename: Grace
authors.initials: G
authors.lastname: Issa
authors.forename: Haifaa
authors.initials: H
authors.lastname: Khalifeh
authors.forename: Robert H
authors.initials: RH
authors.lastname: Habib
authors.forename: Atika
authors.initials: A
authors.lastname: Berry
authors.forename: Nada
authors.initials: N
authors.lastname: Ghosn
authors.forename: Alissar
authors.initials: A
authors.lastname: Rady
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Khalifeh
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007861:Lebanon / Q000453:epidemiology; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy / Q000453:epidemiology* / Q000473:pathology*; D008297:Male; D008536:Meglumine / Q000008:administration & dosage / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D012036:Refugees; D013593:Syria / Q000453:epidemiology; D055815:Young Adult
chemical_list: D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate